When should naltrexone be initiated for alcohol use disorder in inpatient versus outpatient settings?

Naltrexone for Alcohol Use Disorder: Timing of Initiation

Naltrexone should be initiated during hospitalization for alcohol use disorder whenever possible, as inpatient initiation is feasible, safe, and associated with better medication adherence compared to outpatient initiation alone. 1, 2, 3

Key Timing Considerations

Inpatient Initiation is Preferred

Recent evidence demonstrates that 30% of hospitalizations for alcohol use disorder result in medication initiation as an inpatient or within 7 days of discharge 4, though this represents substantial underutilization. When naltrexone is started during hospitalization:

• 97.7% of patients who receive inpatient naltrexone have a prescription filled within 30 days after discharge 4
• Patients initiating after an inpatient stay are more likely to fill a second prescription (aOR 1.43) compared to those starting in outpatient settings 5
• Both oral and injectable naltrexone are feasible to initiate prior to discharge 3

Critical Safety Requirement: Opioid-Free Period

You must ensure patients are opioid-free for 7-10 days minimum before starting naltrexone 1. This is non-negotiable to prevent precipitated withdrawal, which can be severe enough to require ICU admission 1.

Common pitfall: Patients transitioning from buprenorphine or methadone may be vulnerable to precipitated withdrawal for up to 2 weeks, not just 7-10 days 1. Always verify:

• Urine toxicology is negative for opioids (including tramadol)
• No clinical signs of opioid withdrawal
• Consider naloxone challenge test if any doubt exists 1

Practical Inpatient Initiation Protocol

Start with 25 mg on day 1, then advance to 50 mg daily if no withdrawal signs occur 1. This test dose approach is safer than starting at full dose.

For hospitalized patients, you have two equally effective options 2:

• Oral naltrexone 50 mg daily with 30-day prescription at discharge
• Injectable naltrexone 380 mg IM given pre-discharge (provides 30 days coverage)

Both formulations showed equivalent reductions in heavy drinking days (oral: -38.4 percentage points; injectable: -46.4 percentage points; p=0.14) 2. Choose based on patient preference and insurance coverage, not efficacy differences.

When Outpatient Initiation is Necessary

If inpatient initiation isn't possible, outpatient initiation is acceptable but requires:

• Confirmed abstinence from opioids for 7-10 days minimum 1
• Close follow-up within first week
• Integration with evidence-based psychotherapy (CBT, motivational enhancement, or contingency management) 6

Warning: Patients initiating after ED visits are less likely to fill a second prescription (aOR 0.69) compared to office-based initiation 5, so these patients need particularly aggressive follow-up.

Hepatotoxicity Monitoring

Naltrexone can cause hepatotoxicity 1, but recent evidence shows it's safe even in severe alcohol-associated cirrhosis 7. However:

• Obtain baseline liver enzymes
• Warn patients to report symptoms of hepatitis (jaundice, dark urine, right upper quadrant pain)
• Discontinue if acute hepatitis develops 1
• Patients with liver enzymes >200 U/L are less likely to receive naltrexone (likely due to prescriber hesitancy), but this shouldn't be an absolute contraindication 8

Combining with Behavioral Therapy

Naltrexone must be combined with evidence-based psychotherapy - either CBT, motivational enhancement therapy, or contingency management 6. Pharmacotherapy alone with only "usual care" counseling is insufficient. The combination shows effect sizes of 0.18-0.28 compared to usual care 6.

Addressing Low Utilization

Despite evidence, only 19.8% of alcohol withdrawal hospitalizations result in naltrexone initiation 8, with wide variation (5.1%-43.2%) across hospitals. Hospitals with addiction consultation services have significantly higher initiation rates 8. If your hospital lacks this service, advocate for one.

Patients less likely to receive naltrexone include those ≥65 years, those with opioid use disorder comorbidity, and ICU patients 4, 8 - but these exclusions are often inappropriate and represent missed opportunities.

Bottom Line Algorithm

1. During hospitalization: Verify opioid-free status → Start 25 mg test dose → Advance to 50 mg daily OR give 380 mg IM injection pre-discharge
2. Outpatient setting: Confirm 7-10 day opioid-free period → Start 25 mg, advance to 50 mg → Arrange evidence-based psychotherapy
3. All settings: Obtain baseline LFTs, warn about hepatotoxicity, ensure psychotherapy is arranged

The median duration of naltrexone use is only 31 days 5, so aggressive follow-up and adherence support are essential regardless of initiation setting.